AEVIS (AEVIS) Q1 2025 earnings summary

Executive summary

• Consolidated revenues reached CHF 329.7 million in Q1 2025, up 17.0% year-over-year.

• Organic growth in operating divisions was 3.2%, with further momentum from acquisitions.

• Operations performed as expected, with acquisitions from 2024 supporting ongoing growth.

Financial highlights

• Revenue increased to CHF 329.7 million in Q1 2025 from CHF 281.9 million in Q1 2024.

• Swiss Medical Network SA revenue rose 21.4% to CHF 258.6 million.

• MRH Switzerland AG revenue grew 3.7% to CHF 67.1 million.

• Real Estate and Others contributed CHF 4.1 million, slightly down from CHF 4.3 million.

Outlook and guidance

• Full-year growth rate is expected to be maintained, supported by 2024 acquisitions.

• Additional income from non-strategic real estate disposals anticipated for the rest of 2025.